Ignacio
Melero Bermejo
Catedrático de Universidad
Hospital Regional Universitario de Málaga
Málaga, EspañaHospital Regional Universitario de Málaga-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2021
-
OX40 agonist BMS-986178 alone or in combination with nivolumab and/or ipilimumab in patients with advanced solid tumors
Clinical Cancer Research, Vol. 27, Núm. 2, pp. 460-472